Members of HMEB's Editorial Advisory Board share their expert insights on key market and reimbursement trends that are directly impacting providers, as well as business and industry initiatives on which providers must act.
A rehab supplier's view of why H.R. 942 and S. 948 are vitally important.
Diabetes providers face a number of formidable challenges, but they can stay in the game, and also rise to the top through engaging with their patients.
The time for hesitation is past. Providers must act on behalf of H.R. 5083 and H.R. 4920 if they want to fix audits, competitive bidding.
Somewhere dissent and bickering with CMS became the order of the day and it has cost our industry dearly. It is time for a change. Policy administrators and the HME industry need to act as colleagues.
Contact your State and National Organizations.
HME Business' free email newsletter keeping you up-to-date and informed.
Contact the Editor.